abrdn plc Buys Shares of 428,580 Veradigm Inc. (NASDAQ:MDRX)

abrdn plc bought a new stake in Veradigm Inc. (NASDAQ:MDRX) during the 4th quarter, Holdings Channel reports. The firm bought 428,580 shares of the software maker’s stock, valued at approximately $4,496,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Creative Planning boosted its holdings in Veradigm by 2,848.4% in the 3rd quarter. Creative Planning now owns 474,376 shares of the software maker’s stock valued at $6,233,000 after purchasing an additional 458,287 shares during the last quarter. Burney Co. boosted its holdings in Veradigm by 652.8% in the 3rd quarter. Burney Co. now owns 234,094 shares of the software maker’s stock valued at $3,076,000 after purchasing an additional 202,999 shares during the last quarter. Pacer Advisors Inc. boosted its holdings in Veradigm by 108.1% in the 4th quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock valued at $26,399,000 after purchasing an additional 1,307,024 shares during the last quarter. Illinois Municipal Retirement Fund acquired a new position in Veradigm in the 3rd quarter valued at about $825,000. Finally, William Blair Investment Management LLC boosted its holdings in Veradigm by 16.6% in the 3rd quarter. William Blair Investment Management LLC now owns 4,375,005 shares of the software maker’s stock valued at $57,488,000 after purchasing an additional 623,438 shares during the last quarter.

Veradigm Price Performance

Shares of MDRX stock opened at $7.96 on Friday. Veradigm Inc. has a 52 week low of $5.01 and a 52 week high of $14.09. The firm has a 50 day moving average of $7.75 and a two-hundred day moving average of $9.89.

Analysts Set New Price Targets

A number of research firms recently weighed in on MDRX. Royal Bank of Canada lowered their price objective on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a research report on Friday, January 19th. Barclays began coverage on shares of Veradigm in a research report on Wednesday, January 3rd. They set an “equal weight” rating and a $11.00 price objective for the company. StockNews.com began coverage on shares of Veradigm in a research report on Tuesday, April 23rd. They set a “hold” rating for the company. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $10.00 price objective (down previously from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $11.25.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.